JPWO2021125261A1 - - Google Patents
Info
- Publication number
- JPWO2021125261A1 JPWO2021125261A1 JP2021565641A JP2021565641A JPWO2021125261A1 JP WO2021125261 A1 JPWO2021125261 A1 JP WO2021125261A1 JP 2021565641 A JP2021565641 A JP 2021565641A JP 2021565641 A JP2021565641 A JP 2021565641A JP WO2021125261 A1 JPWO2021125261 A1 JP WO2021125261A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019228026 | 2019-12-18 | ||
| JP2019228026 | 2019-12-18 | ||
| PCT/JP2020/047149 WO2021125261A1 (ja) | 2019-12-18 | 2020-12-17 | 高リスク骨髄異形成症候群の治療薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021125261A1 true JPWO2021125261A1 (https=) | 2021-06-24 |
| JP7653712B2 JP7653712B2 (ja) | 2025-03-31 |
Family
ID=76477632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021565641A Active JP7653712B2 (ja) | 2019-12-18 | 2020-12-17 | 高リスク骨髄異形成症候群の治療薬 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7653712B2 (https=) |
| WO (1) | WO2021125261A1 (https=) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040204339A1 (en) * | 2001-04-24 | 2004-10-14 | Dimartino Jorge F. | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
| JP2011520880A (ja) * | 2008-05-15 | 2011-07-21 | セルジーン コーポレイション | シチジン類似体の経口製剤およびその使用方法 |
| JP2013526525A (ja) * | 2010-05-11 | 2013-06-24 | セルジーン コーポレイション | レナリドミド及びアザシチジン併用療法による骨髄異形成症候群の治療方法 |
-
2020
- 2020-12-17 WO PCT/JP2020/047149 patent/WO2021125261A1/ja not_active Ceased
- 2020-12-17 JP JP2021565641A patent/JP7653712B2/ja active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040204339A1 (en) * | 2001-04-24 | 2004-10-14 | Dimartino Jorge F. | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
| JP2011520880A (ja) * | 2008-05-15 | 2011-07-21 | セルジーン コーポレイション | シチジン類似体の経口製剤およびその使用方法 |
| JP2013526525A (ja) * | 2010-05-11 | 2013-06-24 | セルジーン コーポレイション | レナリドミド及びアザシチジン併用療法による骨髄異形成症候群の治療方法 |
Non-Patent Citations (7)
| Title |
|---|
| BLOOD, THE JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY, vol. 133.10, JPN6024049316, 2019, pages 1086 - 1095, ISSN: 0005480254 * |
| MIZOROGI F. ET AL.: "Oral administration of cytarabine ocfosfate and 6-mercaptopurine in elderly patients at high risk fo", JIKEIKAI MED. J., vol. 45, no. 3, JPN6021006299, 1998, pages 57 - 66, ISSN: 0005480259 * |
| PILORGE S. ET AL.: "The autommune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a re", BRITISH JOURNAL OF HAEMATOLOGY, vol. 153, no. 5, JPN6021006295, 2011, pages 664 - 665, ISSN: 0005480256 * |
| WESNER N. ET AL.: "Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective cas", EUR. J. HAEMATOL., vol. 102, JPN6021006296, 2019, pages 63 - 69, ISSN: 0005480257 * |
| 久松理一: "6-チオプリン/アザチオプリン", 薬局, vol. 67, no. 6, JPN6021006293, 2016, pages 27 - 31, ISSN: 0005480255 * |
| 吉田篤史; 遠藤豊; 上野文昭: "Trisomy8 を伴った骨髄異形成症候群に合併した小腸潰瘍", 日本消化器内視鏡学会雑誌, vol. 57.2, JPN6024035190, 2015, pages 170 - 171, ISSN: 0005480260 * |
| 押見和夫ほか: "MDSにおける化学療法および分化誘導療法", 医学のあゆみ, vol. 158, no. 11, JPN6021006297, 1991, pages 729 - 731, ISSN: 0005480258 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021125261A1 (ja) | 2021-06-24 |
| JP7653712B2 (ja) | 2025-03-31 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230929 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240903 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241023 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241210 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250218 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250311 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7653712 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |